Click here to view the United Healthcare (UHC) Medical Policy Updates » November 2024 United…
BCBS Arkansas Medical Policy Updates – February 2023
Click here to view the Blue Cross Blue Shield BCBS Arkansas Medical Policy Updates »
February 2023 BCBS Arkansas Medical Policy Updates:
- Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
- Allogeneic Donor Leukocyte Infusion
- Amniocentesis and/or Chorionic Villus Sampling to Detect Fetal Hereditary or Chromosomal Abnormalities
- Amniotic Membrane and Amniotic Fluid Injections
- Antigen Leukocyte Antibody Test (ALCAT)
- Apheresis, Therapeutic (Plasma Exchange Transfusion)
- Arthroereisis for Pes Planus (Flat Feet) (Subtalar stabilization)
- Artificial Vertebral Disc, Lumbar Spine
- Autism Spectrum Disorder, Early Behavioral Intervention
- Balloon Dilation of the Eustachian Tube
- Belimumab (Benlysta)
- Bevacizumab (Avastin™) for Oncologic Indications
- Biomarker Test (Vectra™ DA) for Monitoring Disease Activity in Rheumatoid Arthritis
- Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Breast Cancer
- Bortezomib (e.g., Velcade)
- Cardiac Event Recorder, Mobile Telemetry
- Certified Nurse Midwives
- Certified Nurse Practitioners
- Clinical Nurse Specialist
- Cryoablation, Radiofrequency Ablation and laser Ablation for Treatment of Chronic Rhinitis
- Cryosurgical Ablation of Primary or Metastatic Liver Tumors
- Digital Health Technologies: Therapeutic Applications
- Electrical Stimulation, Percutaneous Tibial Nerve Stimulation for the Treatment of Voiding Dysfunction
- Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome
- Functional Anesthetic Discography
- Genetic Test: Alpha-1 Antitrypsin Deficiency
- Genetic Test: Alzheimer’s Disease
- Genetic Test: Azothiaprine, 6MP Sensitivity,Genotyping & Phenotyping (TPMT)
- Genetic Test: Cancer Susceptibility Panels Using Next Generation Sequencing
- Genetic Test: Fanconi Anemia
- Genetic Test: Germline Genetic Testing for Pancreatic Cancer Susceptibility Genes
- Genetic Test: Head and Neck Cancer, EGFR Mutation Analysis to Predict Sensitivity to Chemotherapy
- Genetic Test: Miscellaneous Genetic and Molecular Diagnostic Tests
- Genetic Test: Molecular Markers in Fine Needle Aspirates of the Thyroid
- Genetic Test: Molecular Testing of Tumors for Genomic Profiling as a Therapeutic Guide
- Genetic Test: Tamoxifen Treatment (CYP2D6)
- Genetic Test: Testing for the Diagnosis and Management of Mental Health Conditions
- Glucose Monitoring, Continuous
- HDC & Allogeneic or Autologous Hematopoietic Stem Cell Support for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Homocysteine Measurement
- Implantable Bone Conduction Hearing Aids
- Ingestible pH and Pressure Capsule
- Intensity Modulated Radiation Therapy (IMRT), Prostate
- Lab Test: Identification of Microorganisms Using Nucleic Acid Probes
- Laser Treatment of Congenital Port Wine Stain Hemangiomas
- Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes
- Medical Technology Assessment, Non-Covered Services
- Nerve Conduction Studies (NCS), Electromyography (EMG) and Surface EMG (SEMG)
- Neuromuscular Stimulation, Functional
- Non-Invasive Positive Airway Pressure for Chronic Obstructive Pulmonary Disease
- Ocrelizumab (Ocrevus)
- Ophthalmologic Techniques That Evaluate the Posterior Segment for Glaucoma
- Orthoptic Training for the Treatment of Vision and Learning Disabilities
- Pembrolizumab (KEYTRUDA®)
- Percutaneous Angioplasty, Stenting & Atherectomy of the Lower Extremity, Abdominal Aortic & Visceral Arteries
- Percutaneous Arteriovenous Fistula (pAVF)
- Photodynamic Therapy for Dermatologic Conditions
- Physician Assistants
- Preventive Services for Non-Grandfathered (PPACA) Plans: High Blood Pressure Screening in Adults
- Preventive Services for Non-Grandfathered (PPACA) Plans: Overview
- Prostatic Urethral Lift (UroLift System)
- Pulmonary Arterial Hypertension, Pharmacological Treatment with Prostacyclin Analogues, Endothelin Receptors Antagonists, or Phosphodiesterase Inhibitors
- Pulsed Pressure, Treatment for Meniere’s Disease
- Radiation Therapy, Proton Beam or Helium Ion Irradiation, Other than Prostate
- Radioactive Seed Localization of Nonpalpable Breast Lesions
- Risankizumab (e.g., Skyrizi)
- Rituximab (Rituxan), Off-label Use
- Screening for Vertebral Fracture with Dual X-ray Absorptiornetry (DEXA)
- Skin and Soft Tissue Substitutes, Bio-Engineered Products
- Stationary Ultrasonic Diathermy Devices
- Surgery for Morbid Obesity
- Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric Disorders
- Transplant, Composite Tissue Allotransplantation, Hand and/or Face
- Transplant, Heart
- Ultrasonic Ablation of Soft Tissue, Percutaneous
- Ultrasound Treatment for Wounds, Non-Contact
- Vacuum Assisted Closure Device
Click here to view the Blue Cross Blue Shield BCBS Arkansas Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.